HOME » INTERNATIONAL PRODUCTS » INTERNATIONAL INFORMATION REQUEST


Product Information Request for International (Non-USA) Shipments

* First Name:

* Last Name:

Title:

* Company:

* Email:

* Phone:

Fax:

Mobile Phone:

* Address:

* City:

* Zip:

* Country:

* Indicates a required field

Best time to be reached by phone:

Preferred Communication Method:


Send Quote By Email

Auto-Injector Products Available to International Governments:

Quantity

Product Description


ATNAA Auto-Injector  (100 / bx)

ATOX ComboPen  (100 / bx)

AtroPen® 2 mg Auto-Injector (atropine injection)  (12 / bx or 24 / bx)

AtroPen® 1 mg Auto-Injector (atropine injection)  (12 / bx)

AtroPen® 0.5 mg Auto-Injector (atropine injection)  (12 / bx)

AtroPen® 0.25 mg Auto-Injector (atropine injection)  (12 / bx)

Diazepam 10 mg Auto-Injector (diazepam injection)  (15 / bx)

Mark I™, Nerve Agent Antidote Kit (NAAK) (atropine injection and pralidoxime chloride injection)  (30 / bx)

Morphine 10 mg Auto-Injector (morphine injection)  (100 / bx)

Pralidoxime Chloride 600 mg Auto-Injector (pralidoxime chloride injection)  (100 / bx)


ATNAA Trainer - NSN 6910-01-469-0457  (25 / bx)

AtroPen® Trainer - NSN 6910-01-195-4536  (25 / bx)

Diazepam Trainer - NSN 6910-01-275-4833  (25 / bx)

Mark I™ Trainer - NSN 6910-01-194-7251  (25 / bx)

Pralidoxime Chloride Trainer - NSN 6910-01-194-2228  (25 / bx)

You may submit this form below or print the form and fax it to:
Meridian Medical Technologies™, Inc.
Fax:
443.259.7801

IMPORTANT SAFETY INFORMATION: Primary protection against exposure to chemical nerve agents and insecticide poisoning is the wearing of protective garments including masks designed specifically for this use. Individuals should not rely solely upon antidotes such as atropine and pralidoxime to provide complete protection from chemical nerve agents and insecticide poisoning. Seek immediate medical attention after injection with antidotes.

PN MMT3705 © 2007 Meridian Medical Technologies™, Inc. a subsidiary of King Pharmaceuticals®, Inc.